{"id":1876,"date":"2026-11-13T16:01:48","date_gmt":"2026-11-13T08:01:48","guid":{"rendered":"https:\/\/brt-testing.com\/?p=1876"},"modified":"2026-11-13T16:01:48","modified_gmt":"2026-11-13T08:01:48","slug":"ftir-spectroscopy-for-pharmaceutical-analysis","status":"publish","type":"post","link":"https:\/\/brt-testing.com\/tr\/ftir-spectroscopy-for-pharmaceutical-analysis\/","title":{"rendered":"FTIR Spectroscopy for Pharmaceutical Analysis: What a QC Laboratory Can Defend"},"content":{"rendered":"<h2>The Short Answer<\/h2>\n<p><strong>FTIR spectroscopy for pharmaceutical analysis is at its most defensible where the question is identity, and least defensible where the question is what is inside a heterogeneous finished product below the surface.<\/strong> The technique itself is uncontroversial: ASTM E1252 covers general techniques for obtaining infrared spectra for qualitative analysis from 4000 cm\u207b\u00b9 down to 50 cm\u207b\u00b9, for liquid-, solid- and vapour-phase samples <a href=\"https:\/\/store.astm.org\/e1252-98r21.html\" target=\"_blank\" rel=\"noopener\">1<\/a>. What decides whether a result survives a GMP inspection is the fit between the sampling technique and the question. ATR reads roughly 0.5\u20132 \u00b5m into the sample <a href=\"https:\/\/orbi.uliege.be\/bitstream\/2268\/233370\/1\/TrAC_2018_483_Manuscript_REVISED.pdf\" target=\"_blank\" rel=\"noopener\">4<\/a>; a coated tablet is not a surface. This article maps where FTIR belongs in a pharmaceutical QC laboratory \u2014 identity, raw-material confirmation, solid-form screening, stability trending, cleaning support \u2014 and where its limits are, with the regulatory hooks each use carries.<\/p>\n<figure><a href=\"https:\/\/brt-testing.com\/product\/brt-890-ftir-spectrometer\/\"><img decoding=\"async\" src=\"https:\/\/brt-testing.com\/wp-content\/uploads\/2026\/09\/BRT-890-FTIR-Spectrometer.jpg\" alt=\"BRT-890 FTIR spectrometer benchtop instrument used for pharmaceutical identity testing\"><\/a><figcaption>A benchtop FTIR with an ATR accessory covers the majority of pharmaceutical QC identity work; the method, not the instrument, carries the defensible weight.<\/figcaption><\/figure>\n<h2>Where FTIR Fits in a Pharmaceutical QC Laboratory<\/h2>\n<h3>Identity confirmation is the compendial core<\/h3>\n<p>The compendial use is identity. USP general chapter &lt;197&gt;, Spectroscopic Identification Tests, is where infrared identification lives: monographs across the USP-NF cite the infrared test as &lt;197K&gt;, the potassium bromide pellet preparation <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3399637\/\" target=\"_blank\" rel=\"noopener\">18<\/a>, and the chapter&#8217;s procedure instructs recording the spectra of the test specimen and the corresponding USP reference standard over the range from about 2.6 \u00b5m to 15 \u00b5m (3800 to 650 cm\u207b\u00b9) unless otherwise specified in the individual monograph, with the acceptance criterion that the IR absorption spectrum of the preparation corresponds to that of the corresponding reference standard <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7305391\/\" target=\"_blank\" rel=\"noopener\">3<\/a>. That wording sets the operating model for incoming raw materials: compare against a reference spectrum measured under the same preparation, and the comparison \u2014 not a library score alone \u2014 is the test. For most organic excipients and APIs, an ATR accessory makes this a minute-scale, non-destructive measurement, which is why ATR has become the default at goods-in.<\/p>\n<h3>What the technique is, formally<\/h3>\n<p>ASTM E1252 describes the general techniques for qualitative infrared analysis across 4000\u201350 cm\u207b\u00b9 and notes that the techniques are often useful into the near-infrared region as well [1]. Its quantitative sibling, ASTM E168, covers the techniques most often used in infrared quantitative analysis, including computer-based data collection <a href=\"https:\/\/store.astm.org\/e168.html\" target=\"_blank\" rel=\"noopener\">2<\/a>. The division of labour matters for a QC laboratory: qualitative identity is the everyday FTIR task, and quantitative assay by FTIR is possible but must be justified against HPLC alternatives \u2014 regulators expect the method of choice to be the one with the strongest validation story, not the newest instrument.<\/p>\n<h3>The ATR depth problem on finished products<\/h3>\n<p>The single most important physical limitation is sampling depth. A peer-reviewed critical review puts the ATR penetration depth for mid-IR at 0.5\u20132 \u00b5m depending on the crystal and wavenumber, giving a sampled volume of roughly 10 \u00b5m\u00b3, against around 75 mm\u00b3 for NIR reflectance and 10 mm\u00b3 for Raman [4]. The same review notes that finished pharmaceutical products can be relatively inhomogeneous, so a larger sampled volume or multiple spatial points gives more reliable results [4]. In practice: ATR-FTIR on a homogeneous powder or an intact film reads the surface truthfully; ATR-FTIR across a coated, compressed tablet reads a 2 \u00b5m slice of a multi-millimetre object. Two operational consequences follow. First, sample preparation \u2014 scraping, sectioning, grinding to a homogeneous powder for a 197K pellet \u2014 is not a deviation from the technique, it is what makes the technique applicable. Second, any surface-coating claim (coat identity, coat degradation) is one of the few places where the shallow depth is an advantage rather than a defect: depth-resolved ATR-FTIR imaging studies read coating degradation directly because the information depth rarely exceeds 2 \u00b5m <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10301043\/\" target=\"_blank\" rel=\"noopener\">7<\/a>.<\/p>\n<figure><a href=\"https:\/\/brt-testing.com\/product\/brt-860-ftir-spectrometer\/\"><img decoding=\"async\" src=\"https:\/\/brt-testing.com\/wp-content\/uploads\/2026\/09\/BRT-860-FTIR-Spectrometer.jpg\" alt=\"BRT-860 FTIR spectrometer with ATR accessory for raw material identification in a pharmaceutical laboratory\"><\/a><figcaption>Goods-in identity work suits a benchtop FTIR with a fixed ATR: minimal preparation, direct surface contact, comparison against a measured reference.<\/figcaption><\/figure>\n<h2>Solid Form: Polymorphs, Hydrates and What Mid-IR Actually Probes<\/h2>\n<h3>Where mid-IR works and where it does not<\/h3>\n<p>Mid-IR probes vibrations of functional groups, and that is both its power and its polymorph problem. A peer-reviewed evaluation across ten polymorphic pharmaceuticals states it plainly: characterization and discrimination among polymorphs using mid-IR spectroscopy is not always possible in part because the technique mainly probes vibrational modes arising from functional groups, and the far-infrared region offers high discriminating power for polymorphs compared to the mid-infrared spectral region \u2014 a fingerprint for discrimination among polymorphs even if the mid-IR region does not show significant differences <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6486452\/\" target=\"_blank\" rel=\"noopener\">8<\/a>. For a QC laboratory, the honest position is: mid-IR is a fast screen for solid-form differences that express themselves in functional-group bands, hydrate and solvate changes included \u2014 FT-IR is described as probably the quickest and easiest method to investigate hydrates, because hydration changes hydrogen bonding that IR sees directly <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7601571\/\" target=\"_blank\" rel=\"noopener\">9<\/a> \u2014 but a negative mid-IR comparison does not certify the same solid form. Where solid form is the release-critical attribute, XRPD or thermal methods carry the claim, with FTIR as supporting evidence.<\/p>\n<h3>The crystal choice follows the sample<\/h3>\n<p>ATR crystal selection for pharmaceutical work follows three verified numbers. Diamond: depth of penetration 2.0 \u00b5m at 1000 cm\u207b\u00b9, usable pH 1\u201314, chemically and physically robust, with an intrinsic absorption band roughly between 2300 and 1800 cm\u207b\u00b9 <a href=\"https:\/\/www.thermofisher.com\/order\/catalog\/product\/222-247000\" target=\"_blank\" rel=\"noopener\">5<\/a> <a href=\"https:\/\/assets.thermofisher.com\/TFS-Assets\/CAD\/Application-Notes\/TN52598-E%200714M-Smart%20iTX-web.pdf\" target=\"_blank\" rel=\"noopener\">6<\/a>. ZnSe: the same 2.0 \u00b5m penetration, but useful pH limited to 5\u20139 and a low-wavenumber cutoff around 650 cm\u207b\u00b9 \u2014 fine for most organic powders, wrong for strong acids and bases [5][6]. Germanium: 0.66 \u00b5m penetration at 1000 cm\u207b\u00b9 thanks to its high refractive index, which is exactly what you want for strongly absorbing samples [5][6]. Our guide to <a href=\"https:\/\/brt-testing.com\/ftir-atr-crystal-selection-znse-vs-diamond-vs-ge\/\">ATR crystal selection \u2014 ZnSe vs diamond vs Ge<\/a> covers the trade-offs in detail.<\/p>\n<div class=\"brt-table-wrap\" style=\"overflow-x:auto;margin:1.5em 0;-webkit-overflow-scrolling:touch\">\n<table style=\"border-collapse:collapse;width:100%;table-layout:auto\">\n<colgroup>\n<col style=\"width:11.73%\">\n<col style=\"width:17.68%\">\n<col style=\"width:33.64%\">\n<col style=\"width:36.96%\"><\/colgroup>\n<thead>\n<tr>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">Crystal<\/th>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">Penetration at 1000 cm\u207b\u00b9<\/th>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">Useful range notes<\/th>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">Best pharmaceutical fit<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Diamond<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">2.0 \u00b5m<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">pH 1\u201314; intrinsic band ~2300\u20131800 cm\u207b\u00b9<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Universal goods-in work, abrasive or caustic samples<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">ZnSe<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">2.0 \u00b5m<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">pH 5\u20139; cutoff ~650 cm\u207b\u00b9; soft, scratches<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Clean organic powders, excipients<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Germanium<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">0.66 \u00b5m<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">High refractive index; strongly absorbing samples<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Carbon-filled or very dark samples, high-absorbance APIs<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>The Regulatory Frame a Pharmaceutical FTIR Result Lives In<\/h2>\n<h3>Records: the spectra themselves are named in 21 CFR 211<\/h3>\n<p>The strongest regulatory hook for FTIR in pharma QC is explicit. 21 CFR 211.194(a) requires laboratory records to include complete data derived from all tests necessary to assure compliance with established specifications, and paragraph (a)(4) requires a complete record of all data secured in the course of each test, including all graphs, charts, and spectra from laboratory instrumentation <a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/211.194\" target=\"_blank\" rel=\"noopener\">10<\/a>. The spectrum is not supporting material \u2014 it is the record. The same section requires that the suitability of all testing methods used shall be verified under actual conditions of use [10], and paragraph (d) requires complete records of the periodic calibration of laboratory instruments [10]. A benchtop FTIR without a documented PQ, wavenumber verification and a polystyrene calibration record is not producing defensible identity data.<\/p>\n<h3>Method validation: ICH Q2(R2) covers spectroscopic data<\/h3>\n<p>The FDA&#8217;s final guidance Q2(R2) Validation of Analytical Procedures, issued March 2024 alongside Q14 Analytical Procedure Development, provides a general framework for the principles of analytical procedure validation, including validation principles that cover the analytical use of spectroscopic data <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q2r2-validation-analytical-procedures\" target=\"_blank\" rel=\"noopener\">13<\/a> <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q14-analytical-procedure-development\" target=\"_blank\" rel=\"noopener\">14<\/a> <a href=\"https:\/\/www.govinfo.gov\/content\/pkg\/FR-2024-03-07\/pdf\/2024-04834.pdf\" target=\"_blank\" rel=\"noopener\">15<\/a>. That clause matters for every chemometric FTIR method \u2014 identity libraries and PLS quantitation included \u2014 because it closes the old ambiguity about whether multivariate spectroscopic methods fit the classical validation parameters. For stability-indicating claims, Q2(R2) includes demonstration of stability-indicating properties as a defined section [15], and the stability programme itself still runs on Q1A(R2), Stability Testing of New Drug Substances and Products, November 2003 <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q1ar2-stability-testing-new-drug-substances-and-products\" target=\"_blank\" rel=\"noopener\">16<\/a>.<\/p>\n<h3>Testing, trending and stability in EU GMP Chapter 6<\/h3>\n<p>EU GMP Volume 4, Chapter 6, requires that testing methods should be validated, and that a laboratory using a method it did not validate should verify the appropriateness of the testing method <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf\" target=\"_blank\" rel=\"noopener\">11<\/a>. It also requires results of parameters identified as quality attributes to be trended [11], and the on-going stability programme to include relevant physical, chemical, microbiological and biological test methods across the shelf life [11]. FTIR&#8217;s role in that structure: identity at goods-in, solid-form and hydrate checks that feed trend evaluation, and a fast identity re-check on stability time-point samples where the specification allows it.<\/p>\n<h3>Cleaning verification: the honest scope<\/h3>\n<p>EU GMP Annex 15 requires that all analytical test methods used in qualification, validation or cleaning exercises should be validated with an appropriate detection and quantification limit where necessary, that cleaning validation confirms the effectiveness of any cleaning procedure for all product contact equipment, and that sampling is by swabbing and\/or rinsing with recovery shown from all product contact surfaces <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/7c6c5b3c-4902-46ea-b7ab-7608682fb68d_en?filename=2015-10_annex15.pdf\" target=\"_blank\" rel=\"noopener\">12<\/a>. What FTIR contributes is method support \u2014 for example confirming the identity of a residue isolated on a swab \u2014 not a dedicated quantitative swab method; where specific residue testing is not feasible, Annex 15 names total organic carbon and conductivity as representative parameters [12]. Claiming FTIR as a cleaning-validation quantitation technique without that validation story is the kind of gap an inspector finds quickly.<\/p>\n<h2>FTIR, NIR and Raman: Drawing the Boundary<\/h2>\n<div class=\"brt-table-wrap\" style=\"overflow-x:auto;margin:1.5em 0;-webkit-overflow-scrolling:touch\">\n<table style=\"border-collapse:collapse;width:100%;table-layout:auto\">\n<colgroup>\n<col style=\"width:15.7%\">\n<col style=\"width:31.46%\">\n<col style=\"width:27.74%\">\n<col style=\"width:25.09%\"><\/colgroup>\n<thead>\n<tr>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">Dimension<\/th>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">FTIR (mid-IR, ATR)<\/th>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">NIR<\/th>\n<th style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word;background:#f2f4f7;font-weight:600\">Raman<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Sampling depth<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">0.5\u20132 \u00b5m [4]<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">1\u20133 mm, ~75 mm\u00b3 volume [4]<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">1\u20133 mm, ~10 mm\u00b3 volume [4]<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Through packaging<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">No \u2014 requires sample handling and direct contact [4]<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Yes in reflectance<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Yes, generally<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Water interference<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Strong<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Water bands informative (moisture)<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Weak scatterer \u2014 aqueous-friendly [4]<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Best pharma role<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Identity, surface\/coat analysis, solid-form screen<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Moisture, blend uniformity, through-pack ID<\/td>\n<td style=\"border:1px solid #c9ced6;padding:9px 11px;vertical-align:top;overflow-wrap:break-word\">Solid-form, in-process, aqueous<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>The PAT framing from FDA&#8217;s 2004 guidance completes the picture: at-line measurement where the sample is removed and analysed close to the process, on-line where the sample is diverted and may be returned, in-line where it is not removed <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance\" target=\"_blank\" rel=\"noopener\">17<\/a>. ATR-FTIR is inherently an at-line technique because of its contact requirement; NIR owns the in-line slot for moisture and blend endpoints; Raman owns in-process solid-form work. For the broader capability map, see <a href=\"https:\/\/brt-testing.com\/what-is-a-ftir-spectrometer-used-for\/\">what a FTIR spectrometer is used for<\/a>. Peer-reviewed ATR-FTIR imaging has demonstrated in-line dissolution monitoring \u2014 water penetration and polymer erosion rates read directly from images [7] \u2014 but that is a development-laboratory capability, not a routine QC bench method.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h4>Is FTIR acceptable for identity testing under GMP?<\/h4>\n<p>Yes, and it is the compendial default. USP general chapter &lt;197&gt; covers infrared identification \u2014 monographs cite the pellet preparation as &lt;197K&gt; [18] \u2014 and requires the sample spectrum to correspond to the reference standard over the 3800 to 650 cm\u207b\u00b9 range unless the monograph specifies otherwise [3]. What GMP adds around it: 21 CFR 211.194 requires the spectra themselves to be retained as laboratory records and the method&#8217;s suitability verified under actual conditions of use [10].<\/p>\n<h4>Why does ATR sometimes miss what a KBr pellet shows?<\/h4>\n<p>Depth. ATR reads 0.5\u20132 \u00b5m into the sample while a pellet presents a homogeneous bulk [4]. On a coated tablet or a layered granule, the two preparations genuinely interrogate different material. If the release question is bulk composition, grind and pellet (or use transmission); if the question is the surface \u2014 coat identity, degradation, contamination \u2014 ATR&#8217;s shallow depth is the feature [7].<\/p>\n<h4>Can FTIR distinguish polymorphs?<\/h4>\n<p>Sometimes, and never conclusively by mid-IR alone. Mid-IR probes functional-group vibrations, so it discriminates polymorphs only where the form changes those bands; a ten-polymorph evaluation found the far-IR region adds discriminating power that mid-IR lacks [8]. Hydrates and solvates, which change hydrogen bonding, are well within FT-IR&#8217;s reach [9]. For release-critical solid-form claims, use XRPD or thermal analysis with FTIR as support.<\/p>\n<h4>Which ATR crystal should a pharma QC lab buy?<\/h4>\n<p>Diamond for the universal goods-in accessory: pH 1\u201314, robust, 2.0 \u00b5m penetration, accepting an intrinsic band around 2300\u20131800 cm\u207b\u00b9 [5][6]. ZnSe is the economical alternative for clean organic powders but is limited to pH 5\u20139 and scratches [5]. Germanium, at 0.66 \u00b5m penetration, is the choice for strongly absorbing samples [5][6].<\/p>\n<h4>Do I still need KBr pellets if I have ATR?<\/h4>\n<p>For most identity work, no \u2014 ATR is faster and non-destructive, and the &lt;197&gt; comparison procedure accepts any preparation that reproduces the reference spectrum, pellet or ATR [3]. Keep pellet capability for cases where bulk homogeneity or a literature\/compendial reference spectrum measured as a pellet is the comparison basis, and for strongly absorbing or irregular surfaces where contact fails.<\/p>\n<h4>What does ICH Q2(R2) change for FTIR methods?<\/h4>\n<p>It closes the spectroscopy gap explicitly: the final FDA guidance, issued March 2024, states its validation principles cover the analytical use of spectroscopic data [13][15]. For a chemometric identity library or a quantitation model, validate against Q2(R2) parameters \u2014 specificity, range, robustness, and where relevant the stability-indicating demonstration \u2014 rather than improvising a validation design [15].<\/p>\n<h4>Can FTIR be used for cleaning validation?<\/h4>\n<p>As support, not as the quantitation engine, unless you validate it for that job. Annex 15 requires analytical methods used in cleaning exercises to be validated with appropriate detection and quantification limits, sampling by swabbing or rinsing with recovery demonstrated, and names TOC and conductivity as the representative parameters where specific residue testing is not feasible [12]. FTIR fits as the identity confirmation on isolated residues.<\/p>\n<h2>Conclusion: Build the FTIR Role Around the Question<\/h2>\n<p>FTIR spectroscopy for pharmaceutical analysis earns its bench space on identity: compendial, fast, and explicitly recognised in the record-keeping and validation frameworks \u2014 21 CFR 211.194 names spectra, and Q2(R2) names spectroscopic data [10][13]. Extend it to solid-form screening with the mid-IR caveat in mind, use its shallow ATR depth deliberately for surfaces and coatings, and route quantitative and cleaning claims through a validation story before an inspector asks for one.<\/p>\n<p>BRT builds the <a href=\"https:\/\/brt-testing.com\/product\/brt-890-ftir-spectrometer\/\">BRT-890 FTIR spectrometer<\/a> for benchtop QC identity work, the <a href=\"https:\/\/brt-testing.com\/product\/brt-860-ftir-spectrometer\/\">BRT-860 FTIR spectrometer<\/a> for routine multi-user laboratories, and the <a href=\"https:\/\/brt-testing.com\/product\/brt-850-ftir-spectrometer\/\">BRT-850 FTIR spectrometer<\/a> where a compact footprint meets standard ATR workflows. If you are weighing benchtop against portable optics first, start with our <a href=\"https:\/\/brt-testing.com\/ftir-spectrometer-selection-guide-atr-transmission\/\">FTIR spectrometer selection guide<\/a>, then tell us the dosage forms, the batch volumes and the compendial tests on your schedule, and we will match the instrument and accessory set to the method.<\/p>\n<h2>About the Author<\/h2>\n<p>Written by the BRT Testing content team \u2014 Shenyang Baoruitong Automation Equipment Co., Ltd., a manufacturer of fire and flame testing equipment and materials analysis instruments. This article is written for pharmaceutical QC managers and analysts who need spectroscopic results that stand up to a GMP inspection.<\/p>\n<h2>Sources<\/h2>\n<ol>\n<li>ASTM International \u2014 ASTM E1252-98(2021), Standard Practice for General Techniques for Obtaining Infrared Spectra for Qualitative Analysis (official store page). <a href=\"https:\/\/store.astm.org\/e1252-98r21.html\" target=\"_blank\" rel=\"noopener\">https:\/\/store.astm.org\/e1252-98r21.html<\/a><\/li>\n<li>ASTM International \u2014 ASTM E168-16(2023), Standard Practices for General Techniques of Infrared Quantitative Analysis (official store page). <a href=\"https:\/\/store.astm.org\/e168.html\" target=\"_blank\" rel=\"noopener\">https:\/\/store.astm.org\/e168.html<\/a><\/li>\n<li>USP &lt;197&gt; infrared identification procedure text \u2014 reproduced verbatim in Biosorption of dicloxacillin from pharmaceutical waste water using tannin from Indian almond leaf, Biotechnology Reports (2020) (open access). <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7305391\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7305391\/<\/a><\/li>\n<li>Deidda R., Sacr\u00e9 P.-Y., Clavaud M., Co\u00efc L., Avohou H., Hubert P., Ziemons E., Vibrational spectroscopy in analysis of pharmaceuticals: Critical review of innovative portable and handheld NIR and Raman spectrophotometers, TrAC Trends in Analytical Chemistry 114 (2019) 251\u2013259 (author accepted manuscript). <a href=\"https:\/\/orbi.uliege.be\/bitstream\/2268\/233370\/1\/TrAC_2018_483_Manuscript_REVISED.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/orbi.uliege.be\/bitstream\/2268\/233370\/1\/TrAC_2018_483_Manuscript_REVISED.pdf<\/a><\/li>\n<li>Thermo Fisher Scientific \u2014 Smart iTR ATR Sampling Accessory, crystal specifications (official product page). <a href=\"https:\/\/www.thermofisher.com\/order\/catalog\/product\/222-247000\" target=\"_blank\" rel=\"noopener\">https:\/\/www.thermofisher.com\/order\/catalog\/product\/222-247000<\/a><\/li>\n<li>Thermo Fisher Scientific \u2014 Technical Note 52598, Capabilities and Performance of the Smart iTX Accessory (official PDF). <a href=\"https:\/\/assets.thermofisher.com\/TFS-Assets\/CAD\/Application-Notes\/TN52598-E%200714M-Smart%20iTX-web.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/assets.thermofisher.com\/TFS-Assets\/CAD\/Application-Notes\/TN52598-E%200714M-Smart%20iTX-web.pdf<\/a><\/li>\n<li>Advances in ATR-FTIR Spectroscopic Imaging for the Analysis of Tablet Dissolution and Drug Release (peer-reviewed, open access). <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10301043\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10301043\/<\/a><\/li>\n<li>Far-Infrared Spectroscopy as a Probe for Polymorph Discrimination (peer-reviewed, open access). <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6486452\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6486452\/<\/a><\/li>\n<li>Pharmaceutical Hydrates Analysis \u2014 Overview of Methods and Recent Advances (peer-reviewed, open access). <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7601571\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7601571\/<\/a><\/li>\n<li>US FDA \u2014 21 CFR 211.194, Laboratory records (current e-CFR text). <a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/211.194\" target=\"_blank\" rel=\"noopener\">https:\/\/www.law.cornell.edu\/cfr\/text\/21\/211.194<\/a><\/li>\n<li>European Commission \u2014 EudraLex Volume 4, Chapter 6, Quality Control (revision 28 March 2014, official PDF). <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/health.ec.europa.eu\/document\/download\/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf<\/a><\/li>\n<li>European Commission \u2014 EudraLex Volume 4, Annex 15, Qualification and Validation (in operation 1 October 2015, official PDF). <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/7c6c5b3c-4902-46ea-b7ab-7608682fb68d_en?filename=2015-10_annex15.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/health.ec.europa.eu\/document\/download\/7c6c5b3c-4902-46ea-b7ab-7608682fb68d_en?filename=2015-10_annex15.pdf<\/a><\/li>\n<li>US FDA \u2014 Q2(R2) Validation of Analytical Procedures, final guidance, March 2024 (official guidance page). <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q2r2-validation-analytical-procedures\" target=\"_blank\" rel=\"noopener\">https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q2r2-validation-analytical-procedures<\/a><\/li>\n<li>US FDA \u2014 Q14 Analytical Procedure Development, final guidance, March 2024 (official guidance page). <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q14-analytical-procedure-development\" target=\"_blank\" rel=\"noopener\">https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q14-analytical-procedure-development<\/a><\/li>\n<li>US FDA \u2014 Federal Register 89 FR 16582, availability of final guidances Q2(R2) and Q14, 7 March 2024 (official PDF). <a href=\"https:\/\/www.govinfo.gov\/content\/pkg\/FR-2024-03-07\/pdf\/2024-04834.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.govinfo.gov\/content\/pkg\/FR-2024-03-07\/pdf\/2024-04834.pdf<\/a><\/li>\n<li>US FDA \u2014 Q1A(R2) Stability Testing of New Drug Substances and Products, November 2003 (official guidance page). <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q1ar2-stability-testing-new-drug-substances-and-products\" target=\"_blank\" rel=\"noopener\">https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q1ar2-stability-testing-new-drug-substances-and-products<\/a><\/li>\n<li>US FDA \u2014 PAT: A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, guidance for industry, October 2004 (official guidance page). <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance\" target=\"_blank\" rel=\"noopener\">https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance<\/a><\/li>\n<li>Chollet M., Jozwiakowski MJ, Ward JM, Beachy MA, Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection, Drug Development and Industrial Pharmacy 38:10 (2012) \u2014 cites the USP &lt;197K&gt; infrared identification test as a monograph specification (open access). <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3399637\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3399637\/<\/a><\/li>\n<\/ol>\n<p><!-- FAQ \/ Article JSON-LD --><br \/>\n<script type=\"application\/ld+json\">\n{\n \"@context\": \"https:\/\/schema.org\",\n \"@type\": \"FAQPage\",\n \"mainEntity\": [\n  {\n   \"@type\": \"Question\",\n   \"name\": \"Is FTIR acceptable for identity testing under GMP?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"Yes, and it is the compendial default. USP general chapter <197> covers infrared identification \u2014 monographs cite the pellet preparation as <197K> [18] \u2014 and requires the sample spectrum to correspond to the reference standard over the 3800 to 650 cm\u207b\u00b9 range unless the monograph specifies otherwise [3]. What GMP adds around it: 21 CFR 211.194 requires the spectra themselves to be retained as laboratory records and the method's suitability verified under actual conditions of use [10].\"\n   }\n  },\n  {\n   \"@type\": \"Question\",\n   \"name\": \"Why does ATR sometimes miss what a KBr pellet shows?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"Depth. ATR reads 0.5\u20132 \u00b5m into the sample while a pellet presents a homogeneous bulk [4]. On a coated tablet or a layered granule, the two preparations genuinely interrogate different material. If the release question is bulk composition, grind and pellet (or use transmission); if the question is the surface \u2014 coat identity, degradation, contamination \u2014 ATR's shallow depth is the feature [7].\"\n   }\n  },\n  {\n   \"@type\": \"Question\",\n   \"name\": \"Can FTIR distinguish polymorphs?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"Sometimes, and never conclusively by mid-IR alone. Mid-IR probes functional-group vibrations, so it discriminates polymorphs only where the form changes those bands; a ten-polymorph evaluation found the far-IR region adds discriminating power that mid-IR lacks [8]. Hydrates and solvates, which change hydrogen bonding, are well within FT-IR's reach [9]. For release-critical solid-form claims, use XRPD or thermal analysis with FTIR as support.\"\n   }\n  },\n  {\n   \"@type\": \"Question\",\n   \"name\": \"Which ATR crystal should a pharma QC lab buy?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"Diamond for the universal goods-in accessory: pH 1\u201314, robust, 2.0 \u00b5m penetration, accepting an intrinsic band around 2300\u20131800 cm\u207b\u00b9 [5][6]. ZnSe is the economical alternative for clean organic powders but is limited to pH 5\u20139 and scratches [5]. Germanium, at 0.66 \u00b5m penetration, is the choice for strongly absorbing samples [5][6].\"\n   }\n  },\n  {\n   \"@type\": \"Question\",\n   \"name\": \"Do I still need KBr pellets if I have ATR?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"For most identity work, no \u2014 ATR is faster and non-destructive, and the <197> comparison procedure accepts any preparation that reproduces the reference spectrum, pellet or ATR [3]. Keep pellet capability for cases where bulk homogeneity or a literature\/compendial reference spectrum measured as a pellet is the comparison basis, and for strongly absorbing or irregular surfaces where contact fails.\"\n   }\n  },\n  {\n   \"@type\": \"Question\",\n   \"name\": \"What does ICH Q2(R2) change for FTIR methods?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"It closes the spectroscopy gap explicitly: the final FDA guidance, issued March 2024, states its validation principles cover the analytical use of spectroscopic data [13][15]. For a chemometric identity library or a quantitation model, validate against Q2(R2) parameters \u2014 specificity, range, robustness, and where relevant the stability-indicating demonstration \u2014 rather than improvising a validation design [15].\"\n   }\n  },\n  {\n   \"@type\": \"Question\",\n   \"name\": \"Can FTIR be used for cleaning validation?\",\n   \"acceptedAnswer\": {\n    \"@type\": \"Answer\",\n    \"text\": \"As support, not as the quantitation engine, unless you validate it for that job. Annex 15 requires analytical methods used in cleaning exercises to be validated with appropriate detection and quantification limits, sampling by swabbing or rinsing with recovery demonstrated, and names TOC and conductivity as the representative parameters where specific residue testing is not feasible [12]. FTIR fits as the identity confirmation on isolated residues.\"\n   }\n  }\n ]\n}\n<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FTIR spectroscopy for pharmaceutical analysis is most defensible on identity: USP <197> infrared identification, ATR sampling at 0.5-2 micrometres, mid-IR polymorph screening with stated limits, and the GMP hooks (21 CFR 211.194, EU GMP Chapter 6 and Annex 15, ICH Q2(R2)) that decide whether a result survives inspection.<\/p>","protected":false},"author":1,"featured_media":1533,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/posts\/1876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/comments?post=1876"}],"version-history":[{"count":1,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/posts\/1876\/revisions"}],"predecessor-version":[{"id":1877,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/posts\/1876\/revisions\/1877"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/media\/1533"}],"wp:attachment":[{"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/media?parent=1876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/categories?post=1876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brt-testing.com\/tr\/wp-json\/wp\/v2\/tags?post=1876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}